Global Biosimulation Market had crossed a worth of US$ 2.6 Bn in 2021, with a predicted CAGR of 21.5%; the market is estimated to reach revenue of US$ 20.9 Bn by year 2032-end | FMI DUBAI, United Arab Emirates, Dec. 19, 2022 (GLOBE NEWSWIRE) -- The Global Biosimulation Market was valued at US$ 2.6 Bn in 2021 and is expected to reach US$ 20.9 Bn by 2032, finds Future Market...